The Next Great ASX Biotech?

Every once in a while I read a news item that leaves me in a state of semi-shock and, let’s face it, that is a pretty high bar given the messed-up world we live in. This weekend, I spent a bit of time catching up on current affairs (as one does on a lazy Sunday morning) and…

Cynata Therapeutics : The Flip Flop

I make no effort to hide the fact that Cynata (ASX : CYP) is one of the ASX-listed biotechnology companies that I despise the most. It is the worst example of a “hollow chocolate bunny” that will only ever deliver on wild speculation from retail punters wowed by the words “stem cells.” If, one day,…

The Shock Jock : Market Roundup

You give me a royal pain in the ass, if you want to know the truth. – Holden (J.D. Salinger) When I announced earlier in the week that I would no longer be commenting on HotCopper, I thought that would be the end of the annoying, low-intelligence comments mostly aimed at some degree of personal…

2015 : “Year of the Deal”

I thought it was the year of the sheep, but apparently not. One of the toughest aspects of being the CEO or Chairman of any early stage company, is keeping your shareholders engaged with the idea that the deal is just around the corner. In the case of Dr. Stewart Washer, apparently there is strategic value in disclosing to…

Cynata : The Saga Continues

It was actually some activity involving my personal blog that, in some ways, led to the creation of  “The Long Tail”. A week ago I posted a brief commentary (rant?) on Cynata Limited (ASX:CYP), as an example of an underwhelming microcap ASX-listed biotechnology company. I will not repeat the comments I wrote here but you can read the original posting.…